Repositioning Candidate Details
| Candidate ID: | R1311 |
| Source ID: | DB09449 |
| Source Type: | approved |
| Compound Type: | small molecule |
| Compound Name: | Sodium phosphate, monobasic |
| Synonyms: | Disodium hydrogen phosphate anhydrous; Monosodium dihydrogen monophosphate; Monosodium dihydrogen orthophosphate; Monosodium monophosphate; Monosodium phosphate, anhydrous; Phosphoric acid, monosodium salt, anhydrous; Sodium acid phosphate; Sodium biphosphate, anhydrous; Sodium dihydrogen phosphate; Sodium dihydrogen phosphate, anhydrous; Sodium orthophosphate; Sodium orthophosphate monobasic; Sodium phosphate monobasic; Sodium phosphate monobasic (anhydrate); Sodium phosphate monobasic (anhydrous); Sodium phosphate, monobasic; Sodium phosphate, monobasic anhydrous; Sodium phosphate,monobasic; Sodium primary phosphate |
| Molecular Formula: | H2NaO4P |
| SMILES: | [Na+].OP(O)([O-])=O |
| Structure: |
|
| DrugBank Description: | Sodium phosphate is a saline laxative that is thought to work by increasing fluid in the small intestine. It usually results in a bowel movement after 30 minutes to 6 hours. |
| CAS Number: | 7558-80-7 |
| Molecular Weight: | 119.977 |
| DrugBank Indication: | Used to treat constipation or to clean the bowel before a colonoscopy . |
| DrugBank Pharmacology: | Sodium phosphate inceases fecal water content to increase mobility through the large intestine . |
| DrugBank MoA: | Sodium phosphate is thought to work by increasing the amount of solute present in the intestinal lumen thereby creating an osmotic gradient which draws water into the lumen . |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|